- Home
- Member Resources
- Councils and Committees
- Value Programs and Healthcare Policy Committee (VPHP)
Charge
Enable pathologists to be successful in the evolving regulatory and performance measurement environment by developing and promoting policies that address performance measurement, emerging technologies, patient-centric healthcare, and care coordination models. The committee will evaluate and make recommendations to the Council on Government and Professional affairs regarding public health issues and federal policies or regulations that impact the practice of pathology and laboratory medicine. The committee will provide oversight and guidance for the CAP’s qualified clinical data registry for pathologists. The committee will also help to educate pathologists on federal government regulations, quality and performance measurement, and valued-based payment programs.
This committee reports to the Council on Government and Professional Affairs. View a list of the Current Committee Members.
Commitment
Time Commitment Requirements | |
---|---|
Number of face-to-face meetings | 3 |
Length of meetings | 1-2 days |
Typical meeting days | Thursday/Friday or Saturday/Sunday |
Meeting locations | Washington, DC and/or other location |
Number of conference calls | 12 per year; 1 to 1.5 hours each |
Hours/year of committee work required outside of meetings | Chair: 30+ hours per year; plus, participation on CGPA Vice Chair and other members: 10-20 hours per year |
Additional travel or time commitments | None defined |
Activities of Committee
- Support pathologists in changing value-based payment models by advocating for appropriate reimbursement for pathologists and clinical laboratories.
- Advise the CAP regarding Pathologists Quality Registry oversight, quality payment programs/value-based program measure development, and advocacy supporting pathologists and registry users.
- Identify and develop future clinical quality measures and assist in improving clinical data capture via collaboration with other CAP Committees, including Economic Affairs, Quality Practices, Center Guidelines, and others
- Guide the CAP’s policy and advocacy activities related to oversight of laboratories, including governmental agencies such as the Center for Medicare and Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA)
- Analyze and inform the CAP on how changes in science and technology impact the practice of pathology, such as health information technology (HIT), precision medicine, public health, etc.
- Interface with appropriate professional organizations and policymakers to advance the CAP’s engagement in policy and on advocacy activities related to the scope of the committee’s work.
Expertise or Experience
- Interest or experience in reimbursement for pathologists’ work, value-based payment, and/or clinical data registries
- Interest in demonstrating pathologists’ quality and value to the healthcare system using clinical measures and registry data and advocating for pathologists to CMS and other governmental agencies.
- Understanding of oversight of laboratories through the Clinical Laboratory Improvement Amendments (CLIA)
- Knowledge of or involvement with scientific research and application of technological advancements to the laboratory.
Benefits of Committee Membership
- Helping to ensure pathologists have recognized performance measures available to report and demonstrate their value to external stakeholders.
- Learning more about and influencing the evolving payment landscape and how federal regulations interact with CAP accreditation and proficiency testing, which can benefit you and your practice.
- Opportunities to author publications on the topics and work of the committee.
- Sharing the positions of pathologists with other specialties and regulatory agencies as part of advocacy for the profession and specialty of pathology.